Search results
Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support...
Morningstar· 6 days agoTempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm ...
Women denied ‘wonder drug’ that could double terminal breast cancer life expectancy
Daily Telegraph· 4 days agoWomen with HER2-low or ultra-low breast cancer who took Enhertu lived without their cancer growing...
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 8 hours agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who can undergo chemotherapy safely, experts said after finding that some can experience a benefit.
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 5 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
World-First Trial Shows Benefits of Finding, Treating Undiagnosed Asthma, COPD
MedPage Today· 1 day agoIdentifying symptomatic individuals in the community with undiagnosed asthma and chronic obstructive...
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 21 hours agoIn the first quarter, Wainua royalty revenues were $1 million. Wainua generated sales of $5 million...
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC NEWS· 7 days agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 5 days agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
Cramer's Lighting Round: ‘You've got a winner' with Astra Zeneca
NBC Los Angeles· 7 days ago“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to...
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Motley Fool via Yahoo Finance· 4 days agoAmgen is an established big pharma company with a massive pipeline and many avenues for growth...